A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
Clinical trial NCT05745142 · COMPLETED
Trial details
- NCT number
- NCT05745142
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-23
- Primary completion
- 2023-02-23
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.